{"id": "179799", "url": "https://fevir.net/resources/Group/179799", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/metaanalysis-study-group"], "versionId": "4", "lastUpdated": "2025-03-15T21:07:38.067Z"}, "name": "MetaanalysisStudyGroup_Effect_Estimates_for_Mortality_at_14_days_from_COVID19_Remdesivir_vs_Placebo_RCTs", "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>[No data.]</p></div>", "status": "empty"}, "title": "MetaanalysisStudyGroup: Effect Estimates for Mortality at 14 days from COVID19 Remdesivir vs. Placebo RCTs", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "quantity": 3, "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown": "MetaanalysisStudyGroup: Effect Estimates for Mortality at 14 days from COVID19 Remdesivir vs. Placebo RCTs [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179799. Revised 2023-12-04. Available at: https://fevir.net/resources/Group/179799. Computable resource at: https://fevir.net/resources/Group/179799#json."}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Brian S. Alper"}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "179799", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "membership": "conceptual", "description": "Effect Estimates for Mortality at 14 days from COVID19 Remdesivir vs. Placebo RCTs (Biegel 2020 data 35/541 vs. 61/521) (Wang 2020 data 15/153 vs. 7/78) (SOLIDARITY data 219/2743 vs. 219/2708)", "resourceType": "Group", "characteristic": [{"code": {"text": "Member of"}, "exclude": false, "description": "Effect Estimates (Evidence Resources) included in meta-analysis for Mortality at 14 days from COVID19 Remdesivir vs. Placebo RCTs (Biegel 2020) (Wang 2020) (SOLIDARITY)", "valueReference": {"type": "List", "display": "EvidenceList: Effect estimates for meta-analysis (Biegel 2020, Wang 2020, SOLIDARITY)", "reference": "List/179800"}}]}